Can-Fite BioPharma (CANF) Operating Margin Growth (1y) (2016 - 2023)
Powered by 
Analysis
Can-Fite BioPharma (CANF) Operating Margin Growth (1y) (2016 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.12 Bn | 628.36 Bn | 17.26 Bn | 22.00 |
| 2 | AbbVie | 445.86 Bn | 439.29 Bn | 12.70 Bn | 613.00 |
| 3 | Merck | 362.13 Bn | 354.99 Bn | 12.21 Bn | -3,510.00 |
| 4 | Novartis Ag | 268.88 Bn | 261.19 Bn | 11.24 Bn | -164.00 |
| 5 | Pfizer | 156.96 Bn | 145.26 Bn | 10.94 Bn | -611.00 |
| 6 | Sanofi | 52.26 Bn | 44.88 Bn | 10.79 Bn | -572.00 |
| 7 | Revolution Medicines | 42.98 Bn | 42.98 Bn | - | - |
| 8 | Incyte | 25.13 Bn | 20.59 Bn | 1.57 Bn | -194.00 |
| 9 | United Therapeutics | 21.56 Bn | 18.90 Bn | 683.80 Mn | -341.00 |
| 10 | Can-Fite BioPharma | 1.80 Mn | -1.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -27,400.00 |
| Sep 30, 2023 | 30,974.00 |
| Jun 30, 2023 | 10,450.00 |
| Mar 31, 2023 | -22,758.00 |
| Dec 31, 2022 | 106,528.00 |
| Sep 30, 2022 | 13,713.00 |
| Jun 30, 2022 | 23,849.00 |
| Mar 31, 2022 | 31,079.00 |
| Dec 31, 2021 | 39,416.00 |
| Sep 30, 2021 | -22,352.00 |
| Jun 30, 2021 | 62,474.00 |
| Dec 31, 2020 | 3,290.00 |
| Sep 30, 2020 | -93,261.00 |
| Jun 30, 2020 | -25,429.00 |
| Dec 31, 2019 | -153,547.00 |
| Sep 30, 2019 | -26,677.00 |
| Jun 30, 2019 | 28,116.00 |
| Mar 31, 2019 | 32,097.00 |
| Dec 31, 2018 | 1.34 Mn |
| Sep 30, 2018 | -19,381.00 |